Note 6 - Notes Receivable |
3 Months Ended |
---|---|
Mar. 31, 2025 | |
Notes to Financial Statements | |
Financing Receivables [Text Block] |
NOTE 6 – NOTES RECEIVABLE
On January 31, 2025, the Company entered into a binding letter of intent with a third-party seller for the acquisition of 100% of the common stock of a licensed cannabis dispensary in Northern California (the “Target”). In connection with the proposed transaction, Blum Management entered into a senior secured convertible promissory note for $0.50 million with the Target. The note receivable earns interest at a rate of 8.0% per annum and matured on March 31, 2025. At the Company’s option, the promissory note may be converted into shares of the Target, based on a Target valuation of $2.00 million, subject to performance-based adjustments. The promissory note is secured by all assets of the Target. As of March 31, 2025, the note receivable remained outstanding and unconverted. On March 31, 2025, the maturity date of the promissory note was amended to May 30, 2025. The promissory note is recorded at amortized cost, which was $0.50 million as of March 31, 2025. Refer to "Note 24 - Subsequent Events" for the Amended and Restated Binding Letter of Intent dated May 13, 2025. |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The entire disclosure for financing receivable. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|